These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2980561)

  • 1. Action of gadolinium complexes on different enzyme systems.
    Allard M; Caillé JM; Bonnemain B; Meyer D; Simonnet G
    Acta Radiol Suppl; 1986; 369():572-4. PubMed ID: 2980561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gd-DTPA and Gd-DOTA effects on metabolism of glucose and phosphatidylinositols.
    Morris TW; Ekholm SE; Marinetti GV; Prentice LI; Leakey P
    Invest Radiol; 1991 Nov; 26 Suppl 1():S209-11; discussion S232-5. PubMed ID: 1808132
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro interactions of gadolinium DOTA meglumine and gadolinium DTPA meglumine on hemostasis.
    Corot C; Belleville J; Paul J; Baguet J; Amiel M; Eloy R
    Invest Radiol; 1988 Sep; 23 Suppl 1():S261-3. PubMed ID: 3198358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro study of the action of DOTA and DTPA-gadolinium complexes on platelet functions: aggregation and calcium excretion].
    Corot C; Paul J; Belleville J; Eloy R
    J Radiol; 1988 Jan; 69(1):37-8. PubMed ID: 3361466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of gadolinium-DTPA and -DOTA on neural tissue metabolism.
    Morris TW; Ekholm SE; Prentice LI
    Invest Radiol; 1991 Dec; 26(12):1087-90. PubMed ID: 1765443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of gadolinium complexes with metal-dependent biological systems.
    Corot C; Hentsch AM; Curtelin L
    Invest Radiol; 1994 Jun; 29 Suppl 2():S164-7. PubMed ID: 7928218
    [No Abstract]   [Full Text] [Related]  

  • 7. Haemodynamic effects of macrocyclic and linear gadolinium chelates in rats: role of calcium and transmetallation.
    Idée JM; Berthommier C; Goulas V; Corot C; Santus R; Hermine C; Schaefer M; Bonnemain B
    Biometals; 1998 Apr; 11(2):113-23. PubMed ID: 9542065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hemodynamic effects of nonionic and ionic magnetic resonance contrast media in intravenous bolus injection in rats.
    Masui T; Takehara Y; Aoshima R; Kaneko M
    Invest Radiol; 1994 Jun; 29 Suppl 2():S189-91. PubMed ID: 7928226
    [No Abstract]   [Full Text] [Related]  

  • 9. Gd-DOTA: characterization of a new paramagnetic complex.
    Bousquet JC; Saini S; Stark DD; Hahn PF; Nigam M; Wittenberg J; Ferrucci JT
    Radiology; 1988 Mar; 166(3):693-8. PubMed ID: 3340763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging of rat brain glioma: Gd-DTPA versus Gd-DOTA.
    Runge VM; Jacobson S; Wood ML; Kaufman D; Adelman LS
    Radiology; 1988 Mar; 166(3):835-8. PubMed ID: 3401296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium cryptelates as MR contrast agents.
    Knop RH; Frank JA; Dwyer AJ; Girton ME; Naegele M; Schrader M; Cobb J; Gansow O; Maegerstadt M; Brechbiel M
    J Comput Assist Tomogr; 1987; 11(1):35-42. PubMed ID: 3805426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of cardiodepressive effects of gadopentetate dimeglumine with addition of ionic calcium.
    Mühler A; Saeed M; Brasch RC; Higgins CB
    Radiology; 1992 Jul; 184(1):159-64. PubMed ID: 1609076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paramagnetic agents as tracers in magnetic resonance imaging. Extrapolations from Gd-DTPA to everything.
    Koenig SH
    Acta Radiol Suppl; 1990; 374():17-23. PubMed ID: 1966965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal tolerance of gadolinium-DOTA and gadolinium-DTPA in rats.
    Brillet G; Dubois M; Beaufils H; Bourbouze R; Deray G
    Invest Radiol; 1994 Mar; 29(3):352-4. PubMed ID: 8175311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of contrast media in magnetic resonance imaging.
    Bydder GM
    Br J Hosp Med; 1990 Feb; 43(2):149-52. PubMed ID: 2178714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free gadolinium and gadodiamide, a gadolinium chelate used in magnetic resonance imaging: evaluation of their in vitro effects on human neutrophil viability.
    Behra-Miellet J; Gressier B; Brunet C; Dine T; Luyckx M; Cazin M; Cazin JC
    Methods Find Exp Clin Pharmacol; 1996 Sep; 18(7):437-42. PubMed ID: 8900215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal handling and physiologic effects of the paramagnetic contrast medium, gadolinium-DOTA.
    Katzberg RW; Sahler LG; Duda SW; Morris TW; McKenna BA; Pabico RC; Niedrach WL; Tonetti FW
    Invest Radiol; 1991 Nov; 26 Suppl 1():S129-30; discussion S137-8. PubMed ID: 1808108
    [No Abstract]   [Full Text] [Related]  

  • 18. Solvate structures in water-methanol solutions of MRI contrast agents: electron spin echo envelope modulation in gadolinium chelates.
    Clarkson RB; Hwang JH; Belford RL
    Magn Reson Med; 1993 Apr; 29(4):521-7. PubMed ID: 8385260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gd(DOTA): an alternative to Gd(DTPA) as a T1,2 relaxation agent for NMR imaging or spectroscopy.
    Magerstädt M; Gansow OA; Brechbiel MW; Colcher D; Baltzer L; Knop RH; Girton ME; Naegele M
    Magn Reson Med; 1986 Oct; 3(5):808-12. PubMed ID: 3784897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental study of DOTA-gadolinium. Pharmacokinetics and pharmacologic properties.
    Allard M; Doucet D; Kien P; Bonnemain B; Caillé JM
    Invest Radiol; 1988 Sep; 23 Suppl 1():S271-4. PubMed ID: 3198361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.